Journal article
Body Mass Index and Postacute Sequelae of SARS-CoV-2 Infection in Children and Young Adults
JAMA network open, Vol.7(10), e2441970
10/01/2024
DOI: 10.1001/jamanetworkopen.2024.41970
PMCID: PMC11581483
PMID: 39466241
Abstract
Obesity is associated with increased severity of COVID-19. Whether obesity is associated with an increased risk of post-acute sequelae of SARS-CoV-2 infection (PASC) among pediatric populations, independent of its association with acute infection severity, is unclear.
To quantify the association of body mass index (BMI) status before SARS-CoV-2 infection with pediatric PASC risk, controlling for acute infection severity.
This retrospective cohort study occurred at 26 US children's hospitals from March 2020 to May 2023 with a minimum follow-up of 179 days. Eligible participants included children and young adults aged 5 to 20 years with SARS-CoV-2 infection. Data analysis was conducted from October 2023 to January 2024.
BMI status assessed within 18 months before infection; the measure closest to the index date was selected. The BMI categories included healthy weight (≥5th to <85th percentile for those aged 5-19 years or ≥18.5 to <25 for those aged >19 years), overweight (≥85th to <95th percentile for those aged 5-19 years or ≥25 to <30 for for those aged >19 years), obesity (≥95th percentile to <120% of the 95th percentile for for those aged 5-19 years or ≥30 to <40 for those aged >19 years), and severe obesity (≥120% of the 95th percentile for those aged 5-19 years or ≥40 for those aged >19 years).
To identify PASC, a diagnostic code specific for post-COVID-19 conditions was used and a second approach used clusters of symptoms and conditions that constitute the PASC phenotype. Relative risk (RR) for the association of BMI with PASC was quantified by Poisson regression models, adjusting for sociodemographic, acute COVID severity, and other clinical factors.
A total of 172 136 participants (mean [SD] age at BMI assessment 12.6 [4.4] years; mean [SD] age at cohort entry, 13.1 [4.4] years; 90 187 female [52.4%]) were included. Compared with participants with healthy weight, those with obesity had a 25.4% increased risk of PASC (RR, 1.25; 95% CI, 1.06-1.48) and those with severe obesity had a 42.1% increased risk of PASC (RR, 1.42; 95% CI, 1.25-1.61) when identified using the diagnostic code. Compared with those with healthy weight, there was an increased risk for any occurrences of PASC symptoms and conditions among those with obesity (RR, 1.11; 95% CI, 1.06-1.15) and severe obesity (RR, 1.17; 95% CI, 1.14-1.21), and the association held when assessing total incident occurrences among those with overweight (RR, 1.05; 95% CI, 1.00-1.11), obesity (RR, 1.13; 95% CI, 1.09-1.19), and severe obesity (RR, 1.18; 95% CI, 1.14-1.22).
In this cohort study, elevated BMI was associated with a significantly increased PASC risk in a dose-dependent manner, highlighting the need for targeted care to prevent chronic conditions in at-risk children and young adults.
Details
- Title: Subtitle
- Body Mass Index and Postacute Sequelae of SARS-CoV-2 Infection in Children and Young Adults
- Creators
- Ting Zhou - University of PennsylvaniaBingyu Zhang - University of PennsylvaniaDazheng Zhang - University of PennsylvaniaQiong Wu - University of PennsylvaniaJiajie Chen - University of PennsylvaniaLu Li - University of PennsylvaniaYiwen Lu - University of PennsylvaniaMichael J Becich - University of PittsburghSaul Blecker - New York UniversityNymisha Chilukuri - Stanford UniversityElizabeth A Chrischilles - University of IowaHaitao Chu - University of MinnesotaLeonor Corsino - Duke UniversityCarol R Geary - University of Nebraska Medical CenterMady Hornig - Columbia UniversityMaxwell M Hornig-Rohan - RECOVER Patient, Caregiver, or Community Advocate Representative, New York, New YorkSusan Kim - University of California, San FranciscoDavid M Liebovitz - Northwestern UniversityHiroki Morizono - Children's NationalAbu S M Mosa - University of MissouriVitaly Lorman - Children's Hospital of PhiladelphiaChongliang Luo - Washington University in St. LouisNathan M Pajor - Cincinnati Children's Hospital Medical CenterSuchitra Rao - University of Colorado DenverHanieh Razzaghi - Children's Hospital of PhiladelphiaSrinivasan Suresh - University of PittsburghYacob G Tedla - Vanderbilt University Medical CenterLeah Vance Utset - Nationwide Children's HospitalYoufa Wang - Xi'an Jiaotong UniversityDavid A Williams - University of MichiganMargot Gage Witvliet - Lamar UniversityCaren Mangarelli - Lurie Children's HospitalRavi Jhaveri - Lurie Children's HospitalChristopher B Forrest - Children's Hospital of PhiladelphiaYong Chen - University of Pennsylvania
- Resource Type
- Journal article
- Publication Details
- JAMA network open, Vol.7(10), e2441970
- DOI
- 10.1001/jamanetworkopen.2024.41970
- PMID
- 39466241
- PMCID
- PMC11581483
- NLM abbreviation
- JAMA Netw Open
- ISSN
- 2574-3805
- eISSN
- 2574-3805
- Publisher
- AMER MEDICAL ASSOC
- Grant note
- National Institutes of Health: OT2HL161847-01, U01TR003709, U24MH136069, RF1AG077820, 1R01LM014344, 1R01AG077820, R01LM012607, R01AI130460, R01AG073435, R56AG074604, R01LM013519, R56AG069880, R21AI167418, R21EY034179 Patient-Centered Outcomes Research Institute (PCORI) Project Program Awards: ME-2019C3-18315, ME-2018C3-14899
This work was supported in part by National Institutes of Health (grant Nos. OT2HL161847-01, U01TR003709, U24MH136069, RF1AG077820,1R01LM014344,1R01AG077820, R01LM012607, R01AI130460, R01AG073435, R56AG074604, R01LM013519, R56AG069880, R21AI167418, and R21EY034179). This work was supported partially through Patient-Centered Outcomes Research Institute (PCORI) Project Program Awards (grant Nos. ME-2019C3-18315 and ME-2018C3-14899).
- Language
- English
- Date published
- 10/01/2024
- Academic Unit
- Pharmacy; Epidemiology
- Record Identifier
- 9984740853402771
Metrics
20 Record Views